NCT04748172View on ClinicalTrials.gov

COVID-19 Vaccine and Ovarian Reserve

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

June 1, 2023

Study Completion Date

June 1, 2023

Conditions
Fertility IssuesVaccine Adverse Reaction
Interventions
BIOLOGICAL

SARS-CoV-2 virus vaccines

mRNA SARS-CoV-2 virus vaccines ( By Pfizer or Moderna)

DIAGNOSTIC_TEST

AMH sampling

Blood sample for AMH on recruitment and after three months

DIAGNOSTIC_TEST

anti Covid-19 antibody levels (Serology)

Blood sample for IgG against S1 protein after three months

Trial Locations (1)

56506

Sheba Medical Center, Ramat Gan

All Listed Sponsors
lead

Sheba Medical Center

OTHER_GOV

NCT04748172 - COVID-19 Vaccine and Ovarian Reserve | Biotech Hunter | Biotech Hunter